| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |